🧪 The next big thing after GLP-1s

A breakthrough in metabolic health

Weight loss drugs like Ozempic have taken the world by storm, proving that metabolic balance is the future of health.

But what about the millions seeking a cost-effective, safer, and more sustainable solution for overindulgence, inflammation, and next-day recovery?

Enter ​SJP-001​ — a breakthrough in metabolic inflammation management from Sen-Jam.

What does it do?

You may recall Sen-Jam from our ​Deep Dive​.

SJP-001 is Sen-Jam's flagship asset, targeting inflammation caused by alcohol and excess food.

Why the time is now

Have you read ​The Innovator's Dilemma​? This world is primed for disruption.

Big Pharma laser-focused on a costly, prescription-only approach. But the next shift in metabolic health is inevitable — and it's in more accessible, safer, and cost-effective options like SJP-001.

Express interest

Sen-Jam's campaign is closing soon: Apr 7

Clicking the the button below will:

1. Take you to an Expression of Interest form

2. Give Sen-Jam permission to email you

To learn more about Sen-Jam without giving permission to email, ​click here.

📰 Market Headlines

Tech stocks led markets lower ahead of the Fed's rate decision on Wednesday.

• The Nasdaq plunged 1.7%, with the S&P 500 dropping 1.1% and the Dow falling 0.6%.

US homebuilding surged 11.4% in February to 1.108 million units annually as the weather improved.

President Trump and Putin agreed to steps toward a Ukraine peace deal in a 90-minute call, starting with a 30-day ceasefire.

The DOJ sought to remove the judge overseeing a case on deportations of alleged Venezuelan gang members under the Alien Enemies Act.

The two astronauts stuck in space are back on earth.

🐎 Alternative investing news

Have you heard of horse pinhooking?

It’s the practice of buying young horses and reselling them for a profit at a later stage of their development.

 📊 Ideas, trends, and analysis

• Recession risk surged to 36% from 23% in January, with GDP forecasts slashed to 1.7% for 2025 as tariffs overtake inflation as the top economic threat.

 🧠 Make yourself heard

There’s a lot for the Fed to consider with today’s decision. Stocks have been in a sell-off, there are some troubling economic numbers, but inflation is still pesky.

😱 Fear and Greed Index

Earnings

• XPeng reported Q4 revenue of $2.23 billion as shares tumbled almost 8%.

Market movers

• Nvidia unveiled the Blackwell Ultra AI chip at its GTC event, enhancing AI reasoning and boosting data center revenue potential.

• The FTC blocked a second merger attempt between Indiana's Union Health and HCA Healthcare's Terre Haute Regional Hospital.

• CISA's layoffs of 130 cybersecurity workers were ruled unlawful by a federal court, forcing reinstatement with back pay.

• Novartis axed 427 employees in New Jersey following the patent expiration of the heart drug Entresto.

🎤 What you said last time

Cash rules everything around us.

What you had to say:

“If you earn more money you are often granted access to more time off and more abilities.”

📺 What to Watch Today